Deluge of drug ads has FDA struggling to stop the hype

Article Abstract:

The Federal governments efforts to control misleading advertisements for prescription drugs in newspapers and magazines have not kept pace with the growth in drugs advertising. The Food and Drug Administration, which is supposed to protect people from advertisements, which exaggerate the drug benefits, is hobbled by obsolete standards, inadequate staffing and a growing reluctance to get tough with such drug companies.

United States, Legal issues & crime, Government regulation (cont), Government regulation, Advertising, Advertising Activity, Legal/Government Regulation, Metabolic Agents NEC, Metabolic Agents, Laws, regulations and rules, Pharmaceutical industry, Powers and duties, United States. Food and Drug Administration, False advertising

---

Drug firm sells 2 lines to rivals

Article Abstract:

The article is about SmithKline Beecham P.L.C. which said it would sell two product lines to Swiss firms for a combined sum of $2.9 billion. The expected divestitures are necessary to gain approval for SmithKline's proposed $75 billion merger with Glaxo Welcome P.L.C. The Swiss firms are Roche AG and Novartis AG.

Asset sales & divestitures, Acquisitions & mergers, Foreign operations, Switzerland, Anticancer Drugs, Cardiovascular Preparations, Novartis AG, Glaxo Wellcome PLC, Antineoplastic agents, SmithKline Beecham PLC, NOUZ, Cardiovascular agents, Roche A.G.

---

In the drug-sales trenches with an Astra-Zeneca rep

Article Abstract:

The article describes the routine of Anthony Rosato, an Astra-Zeneca P.L.C. pharmaceutical sales representative. Astra-Zeneca is launching prescription drug Nexium as the replacement for Prilosec, which is supposed to lose patent protection this year.

Product introduction, Management development, Pennsylvania, Antiulcer Preps ex Antacids, AstraZeneca PLC, AZN, Antiulcer agents

Similar abstracts:

• Abstracts: Du{ont will sell its drug division to Bristol-Meyers. Merged drug firm to retain local offices. American Home to buy Collegeville complex
• Abstracts: New airport runway waits in the wings. Unique sales approach at unlikely Phila. site. Religious group could spend $35 million in Phila
• Abstracts: Pa. sues 13 drug firms on prices. Cephalon to acquire a Frence drug firm. Huge whistle-blower award resored in SmithKline case

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.